all the information, none of the junk | biotech • healthcare • life sciences

GenMark Seeks to Raise at Least $30M

Xconomy San Diego — 

GenMark Diagnostics (NASDAQ: GNMK), a Carlsbad, CA, maker of automated DNA and RNA diagnostics testing systems, said it plans to raise at least $30 million through a secondary offering of its stock to the public at a price of $4.25 per share. The offering, which is expected to close Wednesday, consists of more than 7 million GenMark shares, with an additional 1 million shares available as an option to cover over-allotments.